Pan-India Distribution & Service
PLA302 Bipolar Electrode (0° Straight) — Joint Tendon Treatment
Spine Devices · RF Plasma Surgical Systems
PLA302

Bipolar Electrode (0° Straight) — Joint Tendon Treatment

The PLA302 (0°) is a straight bipolar RF plasma electrode for tendon disease in the ankle, knee and elbow joints. Low-temperature plasma (40–70°C) treats the tendon with little blood loss, real-time haemostasis and no carbonisation, reducing injury to peripheral tissue.

Clinical Indications
Ankle Tendon Disease
Knee Tendon Disease
Elbow Tendon Disease
Tendinopathy Treatment
Arthroscopic Soft Tissue Work
Joint Tendon Debridement
Key Clinical Advantages
Low-temperature plasma (40–70°C) — Will not cause thermal injury to surrounding tissue, protecting healthy structures around the target site.
Real-time haemostasis — Little blood loss with non-carbonising coagulation keeps the arthroscopic or endoscopic field clear.
Bipolar design — Current stays between the active and return electrodes, reducing injury to peripheral tissue.
Minimally invasive — Light post-operative pain, quick recovery and low recurrence for patients.
Product Specifications
Model Number
PLA302
Type
Bipolar Electrode, 0° Straight Tip
Technology
Plasma RF (Radio Frequency)
Working Temp.
40 – 70°C (Controlled)
Material
Tungsten, Stainless Steel, Platinum
Tip Angle
0° (Straight)
Other
Non-stick surface
Use
Reusable & Disposable
Application
Arthroscopic Tendon Surgery
Certification
CE Marked, CDSCO Compliant
Tendon Ankle Knee Elbow Bipolar CE Certified
Mechan Brand Logo
Authorised Brand
Brand
Manufactured & engineered by Mechan

Mechan is a globally trusted medical device brand dedicated to advancing surgical precision across specialties. Every Mechan product is engineered to exacting international standards — combining cutting-edge technology with clinical ergonomics, so healthcare professionals can deliver better patient outcomes with confidence.

CE & ISO Certified
Internationally approved
Proven Technology
Advanced medical technology
CDSCO Compliant
India market approved